RenovoRx, Inc. (RNXT)
1.33
-0.16
(-10.74%)
USD |
NASDAQ |
Oct 30, 16:00
1.34
+0.01
(+0.75%)
After-Hours: 20:00
RenovoRx Price : 1.33 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.49 | 1.497 | 1.30 | 1.33 | 376395.0 |
| Oct 29, 2026 | 1.43 | 1.52 | 1.43 | 1.49 | 387213.0 |
| Oct 28, 2026 | 1.42 | 1.46 | 1.35 | 1.425 | 173143.0 |
| Oct 27, 2026 | 1.33 | 1.43 | 1.30 | 1.39 | 289416.0 |
| Oct 26, 2026 | 1.30 | 1.34 | 1.27 | 1.31 | 182305.0 |
| Oct 23, 2026 | 1.25 | 1.31 | 1.25 | 1.29 | 284140.0 |
| Oct 22, 2026 | 1.23 | 1.28 | 1.22 | 1.27 | 226268.0 |
| Oct 21, 2026 | 1.20 | 1.29 | 1.18 | 1.23 | 403721.0 |
| Oct 20, 2026 | 1.16 | 1.24 | 1.16 | 1.20 | 264586.0 |
| Oct 19, 2026 | 1.15 | 1.20 | 1.14 | 1.16 | 288465.0 |
| Oct 16, 2026 | 1.21 | 1.22 | 1.14 | 1.14 | 277131.0 |
| Oct 15, 2026 | 1.11 | 1.215 | 1.11 | 1.19 | 328863.0 |
| Oct 14, 2026 | 1.13 | 1.155 | 1.09 | 1.12 | 628406.0 |
| Oct 13, 2026 | 1.243 | 1.27 | 1.135 | 1.15 | 942433.0 |
| Oct 12, 2026 | 1.26 | 1.32 | 1.25 | 1.25 | 256056.0 |
| Oct 09, 2026 | 1.32 | 1.35 | 1.25 | 1.28 | 798789.0 |
| Oct 08, 2026 | 1.33 | 1.37 | 1.31 | 1.33 | 438650.0 |
| Oct 07, 2026 | 1.35 | 1.41 | 1.275 | 1.37 | 594618.0 |
| Oct 06, 2026 | 1.51 | 1.57 | 1.37 | 1.39 | 621683.0 |
| Oct 05, 2026 | 1.58 | 1.61 | 1.43 | 1.47 | 618033.0 |
| Oct 02, 2026 | 1.57 | 1.61 | 1.55 | 1.58 | 269370.0 |
| Oct 01, 2026 | 1.57 | 1.59 | 1.500 | 1.55 | 404025.0 |
| Sep 30, 2026 | 1.57 | 1.64 | 1.54 | 1.56 | 397957.0 |
| Sep 29, 2026 | 1.57 | 1.59 | 1.51 | 1.57 | 370919.0 |
| Sep 28, 2026 | 1.65 | 1.65 | 1.50 | 1.55 | 877001.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 10.71 |
| Travere Therapeutics, Inc. | 50.39 |
| REGENXBIO, Inc. | 7.20 |
| Krystal Biotech, Inc. | 332.29 |
| ACADIA Pharmaceuticals, Inc. | 20.59 |
Price Related Metrics
| PS Ratio | 26.69 |
| Price to Book Value | 6.684 |
| Earnings Yield | -23.61% |
| Market Cap | 60.01M |